Balyasny Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.49M | Sell |
40,328
-1,077,388
| -96% | -$103M | ﹤0.01% | 1528 |
|
|
2025
Q4 | $107M | Buy |
1,117,716
+125,398
| +13% | +$12.2M | 0.14% | 165 |
|
|
2025
Q3 | $94.5M | Sell |
992,318
-1,534,672
| -61% | -$141M | 0.12% | 187 |
|
|
2025
Q2 | $220M | Buy |
2,526,990
+1,940,197
| +331% | +$165M | 0.33% | 46 |
|
|
2025
Q1 | $52.7M | Buy |
586,793
+525,155
| +852% | +$47M | 0.09% | 281 |
|
|
2024
Q4 | $4.92M | Sell |
61,638
-111,911
| -64% | -$9.69M | 0.01% | 1296 |
|
|
2024
Q3 | $15.6M | Buy |
+173,549
| New | +$14.6M | 0.03% | 743 |
|
|
2023
Q3 | – | Sell |
-1,489,800
| Closed | -$131M | – | 2540 |
|
|
2023
Q2 | $131M | Buy |
1,489,800
+1,473,888
| +9,263% | +$127M | 0.29% | 62 |
|
|
2023
Q1 | $1.28M | Sell |
15,912
-656,599
| -98% | -$53.5M | ﹤0.01% | 1646 |
|
|
2022
Q4 | $52.3M | Buy |
672,511
+621,595
| +1,221% | +$50.4M | 0.14% | 181 |
|
|
2022
Q3 | $4.11M | Sell |
50,916
-1,162,482
| -96% | -$104M | 0.01% | 1102 |
|
|
2022
Q2 | $109M | Buy |
+1,213,398
| New | +$123M | 0.35% | 38 |
|
|
2022
Q1 | – | Sell |
-264,894
| Closed | -$27.4M | – | 2694 |
|
|
2021
Q4 | $27.4M | Buy |
+264,894
| New | +$30.7M | 0.09% | 292 |
|
|
2021
Q2 | – | Sell |
-539,447
| Closed | -$67.7M | – | 2189 |
|
|
2021
Q1 | $63.7M | Sell |
539,447
-35,381
| -6% | -$4.15M | 0.31% | 62 |
|
|
2020
Q4 | $67.3M | Sell |
574,828
-284,315
| -33% | -$31.3M | 0.37% | 47 |
|
|
2020
Q3 | $89.3M | Buy |
859,143
+576,553
| +204% | +$57.9M | 0.65% | 11 |
|
|
2020
Q2 | $25.9M | Buy |
282,590
+67,577
| +31% | +$6.48M | 0.22% | 118 |
|
|
2020
Q1 | $19.4M | Sell |
215,013
-667,494
| -76% | -$71M | 0.23% | 126 |
|
|
2019
Q4 | $100M | Buy |
882,507
+149,487
| +20% | +$16.4M | 0.6% | 23 |
|
|
2019
Q3 | $79.6M | Buy |
733,020
+131,861
| +22% | +$13.8M | 0.55% | 24 |
|
|
2019
Q2 | $58.5M | Buy |
601,159
+520,380
| +644% | +$47.5M | 0.37% | 52 |
|
|
2019
Q1 | $7.36M | Sell |
80,779
-1,011,885
| -93% | -$90.6M | 0.05% | 468 |
|
|
2018
Q4 | $99.4M | Sell |
1,092,664
-7,129
| -0.6% | -$666K | 0.72% | 16 |
|
|
2018
Q3 | $108M | Buy |
1,099,793
+58,278
| +6% | +$5.39M | 0.49% | 22 |
|
|
2018
Q2 | $89.2M | Sell |
1,041,515
-669,924
| -39% | -$56M | 0.4% | 42 |
|
|
2018
Q1 | $137M | Buy |
1,711,439
+752,483
| +78% | +$62.1M | 0.57% | 20 |
|
|
2017
Q4 | $77.4M | Buy |
958,956
+946,652
| +7,694% | +$75.8M | 0.24% | 92 |
|
|
2017
Q3 | $957K | Sell |
12,304
-568,783
| -98% | -$47.2M | ﹤0.01% | 1175 |
|
|
2017
Q2 | $51.6M | Buy |
581,087
+429,383
| +283% | +$36.2M | 0.21% | 117 |
|
|
2017
Q1 | $12.2M | Sell |
151,704
-325,176
| -68% | -$25.4M | 0.06% | 424 |
|
|
2016
Q4 | $34M | Buy |
476,880
+386,880
| +430% | +$30.4M | 0.18% | 147 |
|
|
2016
Q3 | $7.78M | Sell |
90,000
-707,149
| -89% | -$61.6M | 0.05% | 437 |
|
|
2016
Q2 | $69.2M | Buy |
+797,149
| New | +$64.5M | 0.45% | 39 |
|
|
2015
Q4 | – | Sell |
-50,000
| Closed | -$3.35M | – | 1355 |
|
|
2015
Q3 | $3.35M | Sell |
50,000
-50,760
| -50% | -$3.74M | 0.02% | 588 |
|
|
2015
Q2 | $7.47M | Buy |
+100,760
| New | +$7.7M | 0.05% | 486 |
|
|
2014
Q4 | – | Sell |
-582,414
| Closed | -$36.1M | – | 777 |
|
|
2014
Q3 | $36.1M | Sell |
582,414
-330,006
| -36% | -$21M | 0.28% | 76 |
|
|
2014
Q2 | $58.2M | Buy |
+912,420
| New | +$55.4M | 0.66% | 22 |
|
|
2014
Q1 | – | Sell |
-334,900
| Closed | -$19.2M | – | 622 |
|
|
2013
Q4 | $19.2M | Buy |
+334,900
| New | +$19M | 0.25% | 108 |
|
|
2013
Q3 | – | Sell |
-80,260
| Closed | -$4.13M | – | 659 |
|
|
2013
Q2 | $4.13M | Buy |
+80,260
| New | +$3.97M | 0.07% | 334 |
|
Other funds holding MDT
VCM
VPM
Balyasny Asset Management's MDT Position: Q1 2026 in Review
Balyasny Asset Management reduced its Medtronic (MDT) stake by 96% in Q1 2026, selling an estimated $103M and leaving 40,328 shares worth $3.49M. The position accounts for ﹤0.01% of the portfolio, ranked #1528.
Balyasny Asset Management first reported a position in MDT in Q2 2013 and has held it in 39 quarters since. The position peaked at $220M in Q2 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Balyasny Asset Management held 40,328 shares of Medtronic worth $3.49M as of Q1 2026.
- Balyasny Asset Management sold 1,077,388 Medtronic shares in Q1 2026, an estimated $103M.
- Medtronic made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1528 holding.
- Balyasny Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 39 quarters since.
- Balyasny Asset Management's Medtronic position peaked at $220M in Q2 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.